Doximity, Inc.

Doximity, Inc.

DOCS
Doximity, Inc.US flagNew York Stock Exchange
26.04
USD
-0.53
- -
4.87BMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.57
0.77
1.16
2.1
2.17
2.5
3.05
3.45
3.53
Basic EPS, GAAP
0.05
0.2
0.28
0.95
0.58
0.78
1.19
1.05
0.9
Free Cash Flow per Basic Share
0.1
0.15
0.44
0.74
0.9
0.94
1.43
1.7
1.6
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
0.01
0.37
4.57
4.98
4.83
5.73
5.19
5.09
Tangible Book Value per Share
- -
- -
0.21
4.43
4.47
4.32
5.25
4.54
4.44
Basic Weighted Avg Shares
151
151
178
163
193
190
187
187
186
Sales/Revenue/Turnover
86
116
207
344
419
475
570
645
656
Operating Margin (%)
8.08
19.04
25.76
33.05
29.86
36.14
40.34
33.33
29.6
Depreciation Expense
1
1
4
5
10
10
11
14
16
Net Income, GAAP
8
30
50
155
113
148
223
196
167
Effective Tax Rate (%)
1.24
- -
13.08
- -
15.27
20.31
15.32
21.58
26.16
Profit Margin (%)
9.14
25.55
24.27
45.05
26.92
31.04
39.13
30.4
25.48
Working Capital
- -
67
107
793
836
766
932
789
764
LT Debt
- -
- -
- -
- -
14
12
10
8
8
Total Equity
- -
1
67
879
966
901
1,083
951
916
Return on Invested Capital (%)
- -
- -
132.61
- -
11.38
14.33
19.27
16.36
14.48
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
5,235.39
147.94
32.75
12.23
15.81
22.5
19.28
17.21

Capital Structure

FRC

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
9
8
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
185
183
180
Market Capitalization
8,191
4,265
3,730

Working Capital

FRC

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
993
944
914
Cash, Cash Equivalents & STI
735
749
688
Accounts Receivable, Net
157
145
178
Inventories
- -
- -
- -
Total Current Liabilities
150
155
150
Payables & Accruals
67
32
33
ST Debt
2
2
2
Deferred Revenue
66
106
109

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
245.52%
-12.17%
Free Cash Flow
- -
33.83%
19.03%
Net Income, GAAP
- -
50.21%
-12.16%
Sales/Revenue/Turnover
- -
26.9%
13.05%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
127
137
169
138
570
2026
146
169
185
145
645
2027
157
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.22
0.24
0.4
0.33
1.19
2026
0.28
0.33
0.33
0.1
1.05
2027
0.13
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Jeffrey A. Tangney
Full Time Employees
880
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
500, 3rd Street San Francisco CA United States of America 94107
IPO Date
Jun 24, 2021
Business
I will refine the search specifically for latest major company changes for Doximity, Inc. to find accurate and recent updates.

Company News

  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS

  • Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt

  • Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Doximity, Inc. (DOCS) Shareholders To Inquire About Securities Fraud Class Action

  • Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Doximity, Inc. (DOCS) Shareholders To Inquire About Securities Fraud Class Action

  • DOCS Shareholder Alert: Doximity, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt

  • SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Doximity, Inc. (DOCS)

  • Shareholders who lost money in shares of acquired Doximity, Inc. (NYSE: DOCS) should contact Wolf Haldenstein Immediately

  • DOCS Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Doximity, Inc. Securities Class Action

  • ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

  • Law Offices of Frank R. Cruz Encourages Doximity, Inc. (DOCS) Shareholders To Inquire About Securities Fraud Class Action

  • Law Offices of Frank R. Cruz Encourages Doximity, Inc. (DOCS) Shareholders To Inquire About Securities Fraud Class Action

  • Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Doximity, Inc. Lawsuit - DOCS

  • Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Doximity, Inc. Lawsuit - DOCS

  • DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit

  • DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit

  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS

  • Kaplan Fox Encourages Doximity, Inc. (DOCS) Investors with Significant Losses to Contact the Firm Before November 16, 2026

  • Doximity Named Leading Clinical AI Benchmark in Fireworks' Cross-Industry Index

  • DOXIMITY LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Doximity, Inc. and Encourages Investors to Contact the Firm